Once daily topical efinaconazole may be a reasonable alternative to treating onychomycosis, according to results of a recent study.
Complex Relationship Between Air Pollutants and Secondary Sensitive Skin in Patients With Acne
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
Social Media and Psoriasis: Addressing Misinformation on TikTok
The Cutaneous Connection: Enhancing Vitiligo Care With Nanette Silverberg, MD
The FDA Approves Deuruxolitinib for Severe Alopecia in Adults
Electroablation Plus Pharmacotherapy Leads to Reduction in Keloid Volume